{"ok":true,"trend":{"id":749807,"platform":"news","region":"global","key":"ai and therapeutic antibody design","title":"AI And Therapeutic Antibody Design","url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPSzFJcXZSYVJBSlo3WUFDSksteHVtTW8zSmlCZXh5NndEbmZQWUhiUlk4NkJCMm1wLTN6UEI3aUhFRGJjLWwyYjhCaFkwNTNwc3UtVVI5N0tfMjBWZl9xaWE5b2lsVlVSbnhFN0g5Q05GQXlYejh0T1k2c0x5OUpGTDZ2TXFQQW13RVZwLW9tUjNHaHdwQWQw?oc=5","first_seen":"2026-10-02T15:36:33.187363Z","last_seen":"2026-10-02T15:36:33.187363Z","last_rank":26,"peak_rank":26,"last_volume":null,"peak_volume":null,"seen_count":1,"score":0.794375,"category_hint":"ai","section":"technology","category":"ai","summary":"Forbes examines how artificial intelligence is transforming the design of therapeutic antibodies, the lab-made proteins behind many modern medicines. AI tools are being used to predict antibody structures, optimise binding and shorten development timelines for new drug candidates. The article reflects growing pharma interest in machine learning to cut costs and speed up the pipeline of antibody-based therapies.","why":"AI is a fast-moving topic in drug development, drawing attention to its practical role in designing antibody therapies.","tone":"positive","entities":["Forbes","artificial intelligence","therapeutic antibodies","pharmaceutical industry"],"summarized_at":"2026-10-02T15:38:30.140542Z","meta":{"via":"scan","lang":"en","term":"ai","source":"forbes.com","published":"Fri, 02 Oct 2026 14:15:00 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"AI Is Reshaping Therapeutic Antibody Design","section_name":"Technology","category_name":"AI","timeline":[{"captured_at":"2026-10-02T15:36:33.187363Z","rank":26,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPSzFJcXZSYVJBSlo3WUFDSksteHVtTW8zSmlCZXh5NndEbmZQWUhiUlk4NkJCMm1wLTN6UEI3aUhFRGJjLWwyYjhCaFkwNTNwc3UtVVI5N0tfMjBWZl9xaWE5b2lsVlVSbnhFN0g5Q05GQXlYejh0T1k2c0x5OUpGTDZ2TXFQQW13RVZwLW9tUjNHaHdwQWQw?oc=5","author":"forbes.com","title":"AI And Therapeutic Antibody Design","snippet":null,"posted_at":"2026-10-02T14:15:00Z","likes":null}],"elsewhere":[],"window":"7d"}}